Is your medication still right for you?

Outro was founded to provide the specialized support our team wishes they'd had

A woman touching a leaf with the Outro graphic of getting off antidepressants (SSRIs, SNRIs, etc.).

Where We started

Our origins are with researchers, patients, and places in between

Outro’s Dr. Mark Horowitz was prescribed an antidepressant while in medical school, on his way to earning a PhD in the neurobiology of depression and the pharmacology of antidepressants. Years later, as a training psychiatrist in the UK, Mark followed traditional guidance to wean himself off his antidepressant, only to experience panic attacks, sleep disruptions, and a depression far worse than anything he had experienced before.

Left searching for solutions, Mark found an online community of thousands of others in similar situations. Founded by our Head of Patient Advocacy, Adele Framer, this community inspired Mark’s research into safely stopping antidepressants and the development of the hyperbolic tapering approach that is now the standard of care in the UK, and the backbone of Outro’s individualized tapering plans.

Having had her own difficulties going off an antidepressant, Adele has dedicated more than a decade to being a lay researcher in and patient advocate for safe tapering, counselling more than 10,000 people through their journeys off medication. We draw on Mark and Adele’s world-leading knowledge to support our team in providing the highest level of care and safety to our members.

Our Values

Our stories have been told time and time again. They start with a prescription to cope with a challenging time in our lives. When we’re ready stop our medication, we follow the guidelines, leading us to experience symptoms we haven’t felt before. Our new symptoms are mistaken as a relapse in our previous condition. We end up convinced we need our medication “like a diabetic needs insulin”. We’ve founded Outro to conclude our stories with what we believe is possible.

People deserve all the information
Medications ≠ subscriptions
Medications need safe endings
More sustainable methods exist
EARLY ACCESS MEMBERSHIPS 
START at $99/month

World Leading Experts

Our People

We're a dedicated team of specialists and people with lived experience, working together to build the safest and most sustainable off-ramp for medication. We’re there when you need us, and cheering you on when you don’t.

Monica Mina
Director of Care

Monica is an adult/acute care nurse practitioner. She has worked in a variety of clinical settings including public health, acute care, and in mental health. Having lived through the experience of antidepressant withdrawal herself it was highlighted to her the lack of expertise and help available in her medical treatment team to discontinue medications safely. She comes to Outro Health with a passion for helping individuals meet their mental health goals while practicing with a holistic client-centered approach.

Dr. Mark Horowitz. founder of Outro Health. Deprescribing antidepressants SSRIs SNRIs
Mark Horowitz, MD, PhD
Co-Founder & Head of Research

Dr. Horowitz is a neuroscientist, Clinical Research Fellow in Psychiatry at the National Health Service in England, and a world-leading researcher in psychiatric medication deprescribing. Mark co-wrote the Royal College of Psychiatrists' guidelines on antidepressant discontinuation, based on the principle of gradual, hyperbolic tapering. His firsthand experience of the difficulty of coming off antidepressants, the lack of professional support, and the help he received through peer support websites inspired him to pursue research and clinical work in safe deprescribing of psychiatric drugs. He co-founded Outro Health to give others the professional support he was unable to find for himself.

Elizabeth Lovell, MD
Psychiatrist

Dr. Lovell is a psychiatrist with an interest in rational psychopharmacology, concurrent disorders and child and adolescent mental health. She completed her general psychiatry residency at McMaster University and has a Masters of Public Health from the University of Edinburgh. Elizabeth is currently completing additional training in the area of child and adolescent psychiatry.

Anthony Yeung, MD
Psychiatrist

Dr. Yeung completed medical school at the University of British Columbia (UBC), followed by a psychiatry residency at the University of Toronto. He subsequently completed subspecialty fellowship training in geriatric psychiatry at UBC and is currently doing a sleep disorder medicine fellowship at UBC. He is a Fellow of the Royal College of Physicians and Surgeons of Canada and Clinical Instructor at UBC.

Adele Framer
Head of Patient Advocacy

Adele Framer is a patient advocate and lay expert in psychiatric drug tapering and withdrawal, having studied it since her own experience with antidepressant withdrawal syndrome, in 2004. She founded a leading peer support website in 2011, offering peer support for tapering, and in 2021 published a well-received paper in Therapeutic Advances in Psychopharmacology.

Olivia Geen, MD
Head of Knowledge Translation

Dr. Geen is passionate about helping healthcare organizations combine research evidence with patient and clinician experience to create personalized care plans. As a physician in both General Internal Medicine and Geriatric Medicine, she specializes in complex disease management and deprescribing in older adults. Olivia is also a Clinical Scholar in the Department of Medicine at McMaster University, caring for patients at both Hamilton General Hospital and Juravinski Hospital, and is currently completing her MSc in Translational Health Sciences at the University of Oxford.

Ellen Vora, MD
Medical Advisor

Dr. Vora is a board-certified psychiatrist, acupuncturist, and yoga teacher, and she is the author of The Anatomy of Anxiety, which looks at how one can overcome anxiety by first understanding it as a physiological response rooted in the body. She takes a functional medicine approach to mental health—considering the whole person and addressing imbalance at the root. Dr. Vora received her B.A. from Yale University and her M.D. from Columbia University.

Raghu Appasani, MD
Medical Advisor

Dr. Appasani is an Integrative & Addiction Psychiatrist with an extensive background in entrepreneurship, neuroscience, global mental health, psychedelics, nutritional/ metabolic health, and psychotherapy. He is currently investigating the applications of psilocybin for mental health conditions at UCSF and additionally operates a concierge's psychiatric practice focused on bridging eastern and western practices.

Hannah Bowers, PhD
Psychology Advisor

Dr. Bowers is a Clinical Psychological and Senior Research Fellow at the University of Southampton. She was the lead psychologist on the REDUCE study, creating and implementing a digital support intervention specifically tailored to individuals coming off their antidepressants in a primary care setting. Beyond antidepressant discontinuation, Dr. Bowers also conducts research into support structures for people dealing with fibromyalgia and IBS.

Michael Apkon, MD
Board Member & Advisor

Dr. Apkon is an experienced healthcare executive, having served as the CEO of SickKids Hospital in Toronto and Tufts Medical Center in Boston. He has held faculty positions at University of Pennsylvania, Yale School of Medicine and Yale School of Management. As a healthcare executive, Dr. Apkon has led systems’ development and improvement to drive high quality and safe care, improve clinical operations, and promote an integrated approach to health care across a continuum of services.

Tyler Dyck founder of Outro Health
Tyler Dyck
Co-Founder & COO

Tyler is an experienced operator with a passion for start-ups and mental healthcare. Most recently, Tyler was an early employee and Director of Finance at Field Trip Health, and before that, the same at HelloFresh Canada. After spending years navigating the troubling yet poorly understood side effects and withdrawal symptoms of antidepressants, Tyler is proud to be supporting Outro’s team and its members in accomplishing their goals.

Brandon Goode founder of Outro Health
Brandon Goode
Co-Founder & CEO

Brandon comes with broad background in the healthcare space. He has a passion for building solutions that help people gain autonomy, and enjoys working with companies that are honest in their missions. Prior to starting Outro, Brandon was the first employee at Field Trip Health, and spent three years at Novo Nordisk's headquarters in Copenhagen. Brandon has degrees in biology, philosophy and global health, and had a past life as an NCAA Division 1 athlete.

Take the first step toward your life, after medication.

Early access memberships start at $99/mo.

100 AVAILABLE

Get Started
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.